e-Profile Login and ID Quick Search
Regulatory and Legislative Initiatives to Protect the Public from Counterfeit and Diverted Drugs (Resolution No. 102-5-06)
Resolution Number: 102-5-06
Title: Regulatory and Legislative Initiatives to Protect the Public from Counterfeit and Diverted Drugs
Action: Passed
Whereas, counterfeit and diverted drugs continue to pose a significant threat to the protection of the public health; and
Whereas, unscrupulous, as well as unsuspecting, wholesale distributors operating in the secondary market often serve as an entry point for the introduction of counterfeit and diverted drugs into the United States drug distribution system; and
Whereas, NABP has developed and is currently in the process of updating the Model Rules for the Licensure of Wholesale Distributors, which address the regulation of wholesale distributors in such a way as to significantly help reduce the chances of counterfeit or diverted drugs entering the US drug distribution system;
THEREFORE BE IT RESOLVED that NABP continue to serve as a resource to the boards of pharmacy and other regulatory agencies that are revising rules and regulations and developing legislation to strengthen the licensure requirements for wholesale distributors through inspections, pedigrees, surety bonds, criminal background checks, increased penalties and fines, and utilization of NABP’s Verified-Accredited Wholesale Distributors program;
THEREFORE BE IT FURTHER RESOLVED that NABP offer educational opportunities addressing appropriate wholesale distributor inspection procedures to board of pharmacy staff.
(Resolution passed at NABP’s 102nd Annual Meeting, San Francisco, CA)
